缺血性卒中合并心力衰竭:急性期管理与结局的相关性
结果显示,31%患者合并心衰,心衰是不良功能结局的独立预测因素,但静脉溶栓和机械再通的安全性与疗效未受影响。
要点
- 急性缺血性卒中患者中心衰患病率为31%。
- 心衰是不良长期功能结局的独立预测因素。
- 心衰未影响静脉溶栓或机械再通的安全性与疗效。
核心结论
- 在真实世界卒中队列中,心衰是不良长期功能结局的独立预测因素,但静脉溶栓和机械再通的安全性与疗效似乎未受影响。
主要发现
- 378例(31%)患者存在心衰。
- 心衰为不良功能结局的独立预测因素。
- 静脉溶栓后症状性颅内出血率心衰组与非心衰组分别为7%与8%(P=0.909)。
- 机械再通或联合治疗后症状性颅内出血率心衰组与非心衰组分别为15%与20%(P=0.364)。
- 入院48小时内早期死亡率两组均低于1.5%。
临床怎么用
- 急性缺血性卒中合并心衰患者仍可考虑静脉溶栓和机械再通治疗。
- 对合并心衰的卒中患者应关注长期功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Heart failure (HF) in patients with acute ischemic stroke constitutes the source of various detrimental pathophysiologic mechanisms including prothrombotic and proinflammatory states, worsening of cerebral tissue oxygenation, and hemodynamic impairment. In addition, HF might affect the safety and efficacy of the acute recanalization stroke therapies. Methods- Patients treated with intravenous recombinant tissue-type plasminogen activator or mechanical recanalization at a universitary stroke center were included into a prospective registry. Patients received cardiological evaluation, including echocardiography, during acute care. Functional outcome was assessed after 90 days by structured telephone interviews. Safety and efficacy of intravenous thrombolysis and mechanical thrombectomy were investigated among patients with HF and compared with patients with normal cardiac function after propensity score matching. Results- One thousand two hundred nine patients were included. HF was present in 378 patients (31%) and an independent predictor of unfavorable functional outcome. Recanalization rates were equal among patients with HF after intravenous thrombolysis and after mechanical recanalization or combined treatment. The rate of secondary intracranial hemorrhage was not different (7% versus 8%; P=0.909 after thrombolysis and 15% versus 20%, P=0.364 after mechanical recanalization or combined therapy). Early mortality within 48 hours after admission was equal (<1.5% in both groups). Conclusions- In this real-world cohort of patients with stroke, HF was an independent predictor of unfavorable functional long-term outcome, while the safety and efficacy of intravenous thrombolysis and mechanical recanalization appeared unaffected.
引用
- Siedler G, Sommer K, Macha K, et al. Heart Failure in Ischemic Stroke: Relevance for Acute Care and Outcome. Stroke. 2019. PMID: 31558143. doi:10.1161/STROKEAHA.119.026139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。